stockrowSS Innovations International, Inc.
SSII Healthcare Medical Devices
SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024.
- Revenue
- +39.4%
- EPS
- −669.2%
- Free cash flow
- −16.6%
- Total debt
- +109.7%
Quarter to June 2026, against a year earlier
Follow SSII
Alert me
SS Innovations International, Inc. (SSII) EV/Sales
As of 5 November 2026, SS Innovations International, Inc. (SSII) trades at a EV/Sales of 7.1×. Over the past ten years it has ranged from 0.0× (December 2023) to 209× (March 2024); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 25.5× | (61.05%) |
| FY2024 | 65.4× | (63.42%) |
| FY2023 | 179× | — |
| FY2022 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 15.7× | (21.35%) |
| Mar 2026 | 20.0× | (21.58%) |
| Dec 2025 | 25.5× | (26.94%) |
| Sep 2025 | 34.8× | (14.81%) |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CERS Cerus Corporation compare | 1.7× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 2.4× |
| NPCE NeuroPace, Inc. compare | 4.5× |
| DCTH Delcath Systems, Inc. compare | 4.5× |
| MASS 908 Devices Inc. compare | 4.9× |
| SI Shoulder Innovations, Inc. compare | 5.4× |
| RCEL Avita Medical Inc. compare | 6.7× |
| SSII SS Innovations International, Inc. | 7.1× |
| SENS Senseonics Holdings, Inc. compare | 8.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)